drugset / Trial / NCT06575036

Sugammadex Dose Finding Under Two Years Old

NCT06575036

Phase 2 Not yet recruiting 33 enrolled Sang-Hwan Ji
NaSequentialOpen-labelTreatment

Summary

This is a prospective dose-finding study of sugammadex for conventional reversal of rocuronium-induced neuromuscular blockade in children under two years of age. This study will explore 50% effective dose and 95% effective dose of sugammadex for reversal of neuromuscular blockade in less than two minutes under biased coin up-and-down method.

Timeline

Start
2024-09-15
Primary completion
2025-04-30
Completion
2025-05-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Sugammadex Other / unclassified 0.5 mg/kg

Indications

No indication recorded.